News

Implementation of GDP for Pharmaceutical Products in Hong Kong

The Pharmacy and Poisons Board of Hong Kong has launched a public consultation on implementing Good Distribution Practice (GDP) for pharmaceutical products in Hong Kong by adopting the PIC/S GDP Guide. Stakeholders are invited to comment on the draft guidance documents. The consultation period runs from 1 April to 31 May 2026.

More
China's NMPA: Guiding Opinions & Q&A on Standardising Modern Pharmaceutical Logistics

China’s National Medical Products Administration (NMPA) has issued new Guiding Opinions on the standardisation of modern pharmaceutical logistics, accompanied by an official Q&A document to address key industry questions.

More
GMDP IWG Three-Year Work Plan: What's Planned for GDP?

The European Medicines Agency (EMA) has published on its website the 3-year work plan (2026–2028) of the GMDP Inspectors Working Group (GMDP IWG) as well as the 2025 annual report. In addition to numerous GMP-related topics, both documents also highlight important aspects that are relevant to the GDP area.

More
Questions and Answers from the ECA Webinar "GDP Update 2026" - Part 2

Around 120 participants attended the ECA Webinar “GDP Update 2026” in March. Many interesting aspects were discussed during the Q&A session. After the event, the speaker, Dr Christian Grote-Westrick, provided written responses to the submitted questions. We have compiled a selection of these questions and answers for you – read Part 2 here, focusing on temperature control.

More
What is Good Distribution Practice (GDP)?

Good Distribution Practice (GDP) ensures that medicinal products maintain their quality, safety, and efficacy throughout the entire supply chain. Consistent implementation is a prerequisite for compliance, patient safety, and successful inspections.

More
FIFO, FEFO, LIFO: What is the meaning?

FIFO, FEFO and LIFO are the three main strategies for warehouse management. But what do the three abbreviations actually stand for and what exactly do they mean?

More
Questions and Answers from the ECA Webinar "GDP Update 2026" - Part 1

Around 120 participants attended the ECA Webinar “GDP Update 2026” in March. Many interesting aspects were discussed during the Q&A session. After the event, the speaker, Dr Christian Grote-Westrick, provided written responses to the submitted questions. We have compiled a selection of these questions and answers for you – read Part 1 here, covering the topics of returns/Swissmedic, the USA, and HPRA.

More
What Requirements must a Responsible Person for GDP meet?

According to the EU Guidelines on Good Distribution Practice (GDP), a wholesale distributor must designate a Responsible Person (RP). The RP plays a key role in ensuring GDP-compliant distribution of medicinal products and can effectively fulfil this role only if appropriately qualified and experienced, and vested with the necessary authority and personal integrity.

More
FIFO, FEFO, LIFO: Was bedeuten diese Abkürzungen?

FIFO, FEFO und LIFO sind wichtige Strategien in der Lagerverwaltung. Doch wofür stehen eigentlich die drei Abkürzungen, und was genau steckt dahinter?

More
Illegal Medicinal Product Imports into Switzerland in 2025: More Consignments, Shifting Countries of Origin

Swissmedic has reported on illegal medicinal product imports and summarised the figures for 2025. Following a slight decline in 2024, case numbers have risen again. Notably, the origin of consignments has shifted: 40 percent now come from Western Europe – particularly from France and Germany.

More
x
Search